NASDAQ NMS - GLOBAL MARKET · MLTX

+0.73% · +$0.0900 · Vol 1.8M

Market closed · last close 4:00 PM ET · price as of 19:47:03 ET

MoonLake Immunotherapeutics

Biotechnology

$12.44

Card

Relationship Map

Follow $MLTX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $MLTX by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measured

Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET · MLTX

Methodology

MLTX

MoonLake Immunotherapeutics

Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET

61/100

Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

61/ 100

Veridion Score

Upper range · HIGH confidence · 6 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: HIGH · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is MLTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move MLTX next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Sep 18
Score
Score moved +6
55/Middle range -> 61/Upper range
Veridion score historySource

About MoonLake Immunotherapeutics

PHARMACEUTICAL PREPARATIONS

Listed since

2022

Employees

130

Country

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$12.28

Day high

$12.50

Day low

$12.09

Previous close

$12.35

52W high

$61.99

-79.93% from high

52W low

$6.25

11% of range

Market cap

$1.1B

EPS

$-3.7900

Beta

0.97

Shares out

85.1M

Volume

1.8M

1.15× rel vol

Avg volume

1.6M

VWAP

$12.32

Price history computed in-house

-0.56%

-21.61%

-35.24%

-76.87%

YTD

-5.61%

SMA 50 $16.66 · below

SMA 200 $16.88 · below

52W position 11%

MLTX overview

Veridion Score

Registered · 2026-09-18

6 of 6 factors measured

Latest receipt rows

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around MLTX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

MLTX insider activity

MoonLake Immunotherapeutics

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not evaluated: the receipt-backed Form 4 snapshot could not be read

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not evaluated: the receipt-backed Form 4 snapshot could not be read.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in MLTX

Congress tracker Open ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for MLTX in the cached public ledger.

Federal contracts

MLTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for MLTX in this window.

Lobbying spend

MLTX lobbying filings, year to date.

Registered lobbying filings matched to MoonLake Immunotherapeutics.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for MLTX in this window.

Analyst ratings

Sovereign unlock shows live analyst consensus for MLTX.

Options

Sovereign unlock shows live options positioning for MLTX.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Methodology

No related ticker met the data requirements for this rail.

Follow $MLTX

Why is MLTX moving today?

What can move MLTX next.

MLTX overview

Related filings and maps

MLTX insider activity

MLTX contract awards, year to date.

MLTX lobbying filings, year to date.

Cross-references from this score page.

What can move MLTX next.

MLTX insider activity

Cross-references from this score page.